The Claim
In female Wistar rats with D-galactose-induced accelerated aging and estrogen deprivation, spermidine administration reduces cardiac apoptosis by decreasing the Bax/Bcl-2 ratio and reducing the number of TUNEL-positive cardiomyocytes without altering cardiac senescence markers.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In female Wistar rats with accelerated aging and low estrogen, spermidine decreases heart cell death by lowering the Bax/Bcl-2 protein ratio and reducing TUNEL-positive heart cells, without changing markers of cellular aging.
See the scientific wording
In female Wistar rats with D-galactose-induced accelerated aging and estrogen deprivation, spermidine reduced cardiac apoptosis by lowering the Bax/Bcl-2 ratio and decreasing TUNEL-positive cardiomyocytes, without altering cardiac senescence markers.
Spermidine fixes damaged heart cell power plants by stopping excessive splitting and reducing harmful chemicals they produce. This prevents the power plants from leaking signals that trigger cell death, which lowers the ratio of death-promoting to survival proteins and stops heart cells from dying.
What the research says
1 studyIn aging, estrogen-deprived rats, giving spermidine helped reduce heart cell death without making the cells any younger—just like the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.